Gubra A/S (GUBRA.CO)

DKK 728.0

(2.82%)

Operating Expenses Summary of Gubra A/S

  • Gubra A/S's latest annual operating expenses in 2023 was 164.35 Million DKK , up 57.25% from previous year.
  • Gubra A/S's latest quarterly operating expenses in 2024 Q1 was 48.73 Million DKK , up 14.19% from previous quarter.
  • Gubra A/S reported a annual operating expenses of 99.03 Million DKK in annual operating expenses 2022, up 28.27% from previous year.
  • Gubra A/S reported a annual operating expenses of 77.2 Million DKK in annual operating expenses 2021, up 0.94% from previous year.
  • Gubra A/S reported a quarterly operating expenses of 48.73 Million DKK for 2024 Q2, down 0.0% from previous quarter.
  • Gubra A/S reported a quarterly operating expenses of 38.95 Million DKK for 2023 Q1, up 110.13% from previous quarter.

Annual Operating Expenses Chart of Gubra A/S (2023 - 2020)

Historical Annual Operating Expenses of Gubra A/S (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 164.35 Million DKK 57.25%
2022 99.03 Million DKK 28.27%
2021 77.2 Million DKK 0.94%
2020 76.48 Million DKK 0.0%

Peer Operating Expenses Comparison of Gubra A/S

Name Operating Expenses Operating Expenses Difference
ALK-Abelló A/S 2.36 Billion DKK 93.062%
Bavarian Nordic A/S 3.02 Billion DKK 94.565%
Genmab A/S 10.92 Billion DKK 98.496%
Novo Nordisk A/S 93.92 Billion DKK 99.825%
Orphazyme A/S 27.04 Thousand DKK -607691.872%
Pharma Equity Group A/S 24.81 Million DKK -562.367%
Zealand Pharma A/S 226.92 Million DKK 27.575%